Lilly announces positive results for Emgality from CONQUER study

This article was originally published here

The CONQUER study was designed and conducted based on findings from subgroup analyses of prior Phase 3 studies of Emgality, which suggested it may be an option for

The post Lilly announces positive results for Emgality from CONQUER study appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply